Cervical Cancer Screening

Slides:



Advertisements
Similar presentations
HPV Testing and Genotyping
Advertisements

Update:Pap Smear Guidelines
Cervical Screening Guidelines - for now and the future - Meg McLachlin, MD, FRCPC.
MANAGEMENT OF THE ABNORMAL PAP SMEAR
Cervical Cancer. Dr. Swapna Chaudhary M.S. (MUM) Consultant Obstetrician & Gynaecologist Infertility Specialist.
Cervical Cancer American Cancer Society Georgia Department of Human Resources The University of Georgia Cooperative Extension Service.
IL BCCP Questions.
Updates on Pap Smear Guidelines 2014
ASHLYN SAVAGE, MD, MSCR ASSOCIATE PROFESSOR OBSTETRICS AND GYNECOLOGY MEDICAL UNIVERSITY OF SOUTH CAROLINA Managing Abnormal Pap Smears: Incorporating.
Cervical Cancer Screening Cristin Colford, MD April 27,2010.
Screening for Cervical Cancer
Management of Women with CIN 1 or LSIL
Interim Guidance for the Use of Human Papillomavirus DNA Testing as an Adjunct to Cervical Cytology for Screening Obstetrics and Gynecology, Volume 103,
Clinical Uses of HPV DNA Testing
Cervical cancer prevention update
C ERVICAL C ANCER S CREENING U PDATE Based on the 2012 Recommendations (ASCCP) Sarah Lamanuzzi, MD, FAAFP.
Cervical Cancer Screening
Screening Tests for Brest & Cervical Cancer
Review of the Guidelines for Cervical Screening in New Zealand Presentation for smear-takers September 2008.
CANCER CERVIX A PREVENTABLE CANCER Dr NEETA DHABHAI Sr Consultant. – Gynaecologist Member Expert - Indian Cancer Winners’ Association
Cervical Cancer in California Janet Bates, MD MPH Research Program Director Research and Surveillance Program California Cancer Registry.
Women’s First Health Center Drs. Sylvester, Youngren, Lo and Sansobrino What You Should Know About Cervical Cancer: Part one in a series of four updates.
Adolescent Gynecology Amy Gregory Weeks, M.D. Vanderbilt University School of Medicine February 20, 2007.
Screening for Cervical Cancer Max Brinsmead MB BS PhD May 2015.
SoftPAP® A Novel Collection Device for Cervical Cytology.
Current guidelines for Cervical Cancer Screening
Hot Topics Clinical Medicine ACHA Annual Meeting Boston, MA May 31, 2013.
Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Screening.
Cervical Intraepithelial Neoplasm
Top Pap smear Questions. 1-When should Pap screening begin? Age 21 y/o,3yrs after first intercourse.
Cervical Cancer Screening Guidelines Update
Sarah Feldman MD MPH Co-Director Ambulatory Gynecologic Oncology Brigham & Women’s Hospital Dana Farber Cancer Institute Lowell Cancer Center Associate.
Premalignant lesions of the cervix. Applied anatomy.
Screening of genital cancers Evidence Based Presented by Dr\ Heba Nour.
2006 ASCCP Consensus Guidelines Anne L. Kittendorf, MD FAAFP Assistant Professor University of Michigan Department of Family Medicine.
HPV and Pap Guidelines Jennifer Johnson MD. Objectives 1. Define the new PAP guidelines. 2. Identify the historical trends and new evidence resulting.
Kathy A. King, MD Assistant Professor of OB/GYN Medical Director, PPWI
To pap or not to pap: and what to do when you do Kimberly Swan MD Minimally Invasive Gynecologic Surgery Assistant Professor Ob/Gyn University of Kansas.
Date of download: 6/21/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Cervical Cancer Screening With Both Human Papillomavirus.
Cytopathology Feb
New Technologies in cervical cancer screening Cosette Wheeler, University of New Mexico Albuquerque, New Mexico.
Cervical Cancer Screening NURS 541: Women’s Healthcare – Diagnosis and Management.
VETERANS HEALTH ADMINISTRATION The Pelvic Exam including Cervical Cancer Screening.
Update on Cervical Cancer Screening Barbara S. Apgar, MD, MS Professor of Family Medicine University of Michigan Health System Ann Arbor, Michigan.
1 Cervical Cancer Screening Updates Dr. GORDON JOHNSON.
Public Health England leads the NHS Screening Programmes
Trreatment of Preinvasive Lesions
Colposcopic Biopsy Results of HPV 16 and 18 patients in Bartın
Cancer Screening Guidelines
Please go to: polleverywhere
Cervical Cancer in California
Cervical Cancer Colposcopy & Treatment
From: Inefficiencies and High-Value Improvements in U. S
Risk factors for cervical intraepithelial neoplasia recurrence after loop electrosurgical excision procedure in HIV-1-infected and non-infected women.
Dr N Shailaja Dr Pradeep
Colposcopy triage. Satisfactory colposcopy is defined as complete visualization of the squamocolumnar epithelium, which comprises the cervical region most.
Module 2: Cervical Cancer Screening Guidelines, 2012
Premalignant Cervical Disease and Delayed HPV Vaccination
Updates on Pap Smear Guidelines 2014
“Take the Test: Not the Risk” HPV and Cervical Cancer
Public Health England leads the NHS Screening Programmes
AGC&AIS Setareh Akhavan M.D Gynecologist Oncologist
Cervical Screening for Dysplasia and Cancer in Patients with HIV
What is a Pap smear? A Pap smear (also known as the Pap test) is a medical procedure in which a sample of cells from a woman's cervix (the end of the uterus that.
Cervical excisional treatment of young women: A population-based study
SH-sheikhhasani Gyn-oncologist
The National Cervical Screening Programme
Modern cervical cancer screening
American Society of Cytopathology’s CELL Talks
Presentation transcript:

Cervical Cancer Screening and Management Barbara S. Apgar, MD, MS FM Update Course October 20, 2016 Slide 1 This presentation on Cervical Cancer Screening was developed by the American Society for Colposcopy and Cervical Pathology (ASCCP) to assist all clinicians caring for women in understanding the current primary recommendations for cervical cancer screening published by the American College of Obstetricians and Gynecologists (ACOG) and the American Cancer Society (ACS) and the basis for the recommendations. The discussion will also focus on the new option of co-testing of women with cervical cytology and HPV DNA tests, as it is the least understood of the screening options.

Disclosures 1. Apgar B, Brotzman G, Spitzer M Disclosures 1. Apgar B, Brotzman G, Spitzer M. Integrated Text and Atlas of Colposcopy. Elsevier Publishers, 2004, 2008. 2. Brotzman G, Spitzer M, Apgar B. Colposcopic Image Library on CD. SABK, Inc 2004. 3. ASCCP Board of Directors. 2007-current.

Let’s do some cervical cancer screening cases to get started!

A 20 year old G1P1 presents for contraception A 20 year old G1P1 presents for contraception. She has had annual Pap's (all normal) since her pregnancy at age 16. She has had 7 partners since age 15 and a new partner for 3 months. What would you advise her about cervical cancer screening? No Pap test now but at age 21. Pap test now and annually because of multiple partners. 3. HPV testing now. 4. Pap test and HPV testing at age 21.

Query the daughter without the mother. STI test her now, no Pap. The mother of a 17 year old comes in with her daughter because she found her OCPs. The daughter told her she had been sexually active for 2 years with multiple partners. Mother wants her tested for all STI’s and wants her to have a Pap test. She has not received the HPV vaccine series. What do you do? Query the daughter without the mother. STI test her now, no Pap. Pap and STI test her now. Pap and HPV at age 21. STI testing and Pap at age 21.

2012 Consensus Guidelines When to begin screening Women younger than 21 Years: No screening. Saslow et al. ACS/ASCCP/ASCP. CA Cancer J Clin 2012; 62: 147-72 and AJCP 2012; 137: 516 – 542. Moyer VA, et al. USPSTF. Ann Int Med 2012; 156: 880-91 ACOG Practice Bulletin #131, November 2012 NCCN Cervical Cancer Screening Guideline v. 2-2012. www.NCCN.org

A 21 year old comes in for her first cervical cancer screening A 21 year old comes in for her first cervical cancer screening. She is sexually active. Assuming Pap is negative, when is her next screening? 1 year, Pap only. 2 years, Pap only. 3 years, Pap only 3 years, Pap and HPV testing.

2012 Consensus Guidelines: Screening Frequency Age 21-29. Testing with cytology (Pap) alone every 3 years. Co-testing should NOT be performed for women under age 30. Reflex HPV testing for ASCUS only. Saslow et al. ACS/ASCCP/ASCP. CA Cancer J Clin 2012; 62: 147-72 and AJCP 2012; 137: 516 – 542. Moyer VA, et al. USPSTF. Ann Int Med 2012; 156: 880-91 ACOG Practice Bulletin #131, November 2012 NCCN Cervical Cancer Screening Guideline v. 2-2012. www.NCCN.org

Risk in young women, not exactly adolescents The risk of cervical cancer is 10-fold higher than risk in adolescents (1.4/100,000). High enough to justify screening. ~ 55,000 Pap's must be obtained for every cervical cancer diagnosed. Low enough to allow observation for minor cytologic abnormalities.

A 21 year old had a negative Pap 2 years ago while pregnant A 21 year old had a negative Pap 2 years ago while pregnant. What screening should be done now? Pap now. Pap and HPV testing now. No Pap needs to be done now.

21 year old G2P0 on Depo. She presents for her first cervical cancer screening. Multiple partners for 3 years. Pap shows ASC-US, reflex HPV type 16 + What is the next step? Immediate colposcopy. Pap in one year. Pap and HPV in one year. Routine screening (Pap in 3 years).

ASCUS or LSIL in young women – very common cytologic diagnosis in this age group Not for LSIL 2 years

She returns in one year. Her Pap is still ASCUS. What is the next step? Immediate colposcopy. Pap in one year. Pap and HPV in one year. Routine screening.

ASCUS or LSIL in young women Not for LSIL 2 years

A 31 year old has not had a Pap test in 3 years A 31 year old has not had a Pap test in 3 years. What is her “preferred” cervical cancer screening? Co-testing (Pap and HPV) now. Pap only now. No screening now.

2012 Consensus Guidelines: Screening Frequency Age 30-65. Testing with cytology alone every 3 years or co-testing with cytology and testing for high-risk HPV types every 5 years. Co-testing “preferred” and cytology “acceptable” by all but USPSTF. USPSTF says either acceptable. Saslow et al. ACS/ASCCP/ASCP. CA Cancer J Clin 2012; 62: 147-72 and AJCP 2012; 137: 516 – 542. Moyer VA, et al. USPSTF. Ann Int Med 2012; 156: 880-91 ACOG Practice Bulletin #131, November 2012 NCCN Cervical Cancer Screening Guideline v. 2-2012. www.NCCN.org

45 year old G2P2 presents as a new patient. No history of abnormal Paps. Last Pap 3 years ago.  New sexual partner for 6 mos. Monogamous prior. What is the preferred cervical cancer screening ? 1. Pap now and then annually since she has a new partner. 2. Pap test/HPV co-testing now and if both negative, repeat every 5 years. 3. Pap test now and if normal, every 3 years. 4. No cervical cancer screening is needed today.

A 51 year old postmenopausal woman had a LEEP 2 years ago for CIN 3 A 51 year old postmenopausal woman had a LEEP 2 years ago for CIN 3. 2 negative Pap's since then. She had a TAH for fibroids 6 months ago. What would you advise her about vaginal cancer screening? She does not need further Pap tests. She should have Pap tests until age 65 and then discontinue. Routine age based screening for 20 years.

Diagnostic Excisional Management of Women with Biopsy-confirmed Cervical Intraepithelial Neoplasia - Grade 2 and 3 (CIN2,3) * Inadequate Colposcopy or Recurrent CIN2,3 or Endocervical sampling is CIN2,3 Adequate Colposcopy *Management options will vary in special circumstances or if the woman is pregnant or ages 21-24 †If CIN2,3 is identified at the margins of an excisional procedure or post-procedure ECC, cytology and ECC at 4-6mo is preferred, but repeat excision is acceptable and hysterectomy is acceptable if re-excision is not feasible. Either Excision† or Ablation of T-zone * Diagnostic Excisional Procedure † Cotesting at 12 and 24 months 2x Negative Results Evaluation for recurrent disease Any test abnormal The initial management of CIN2,3 includes either excision or ablation of the transformation zone or a diagnostic excisional procedure should colpo be inadequate or recurrent high grade disease is present. In follow up, any abnormal test should begin more intensive surveillance for recurrent disease. Repeat cotesting in 3 years Colposcopy With endocervical sampling 20 years Routine screening Figure 16 © Copyright, 2013, American Society for Colposcopy and Cervical Pathology. All rights reserved.

You are considering stopping cervical cancer screening in a 65 year old woman who has never had an abnormal Pap. She has not had co-testing but had 2 Pap's in the past 10 years with the most recent one 6 years ago. Is her screening “adequate” enough to stop screening? 1. Yes 2. No

Adequate screening: ACOG, ASCCP, ACS* Adequate negative prior screening is defined as: 3 consecutive negative cytology results OR 2 consecutive negative co-tests done within the 10 years before stopping screening with the most recent test within 5 years. *USPSTF does not define adequate screening

A 71 year old widow is dating several widowed men A 71 year old widow is dating several widowed men. She has always had negative Pap's. Does she need screening? No Yes Depends if any of the men had a wife with cervical cancer.

A 69 year old woman’s husband died 5 years ago A 69 year old woman’s husband died 5 years ago. She has no hx abnormal Pap's and her last Pap was at age 66. New sexual partner. What would you advise her about cervical cancer screening? Pap test only now. Pap and HPV testing now. Pap test 3 years after resuming sexual activity. No further Pap test is necessary.

2012 Consensus Guidelines: When to stop screening Women older than 65 Years: After adequate negative prior screening results. Women with a history of CIN2, CIN3, or AIS should continue routine age-based screening for at least 20 years. Screening should not be resumed for any reason, even if a woman reports having a new sexual partner. Saslow et al. ACS/ASCCP/ASCP. CA Cancer J Clin 2012; 62: 147-72 and AJCP 2012; 137: 516 – 542. Moyer VA, et al. USPSTF. Ann Int Med 2012; 156: 880-91 ACOG Practice Bulletin #131, November 2012 NCCN Cervical Cancer Screening Guideline v. 2-2012. www.NCCN.org

A 55 year old had a hysterectomy for fibroids 3 years ago A 55 year old had a hysterectomy for fibroids 3 years ago. She has had 3 normal Pap's since then. She had normal Pap's prior to the TAH. What would you advise her about vaginal cancer screening? Continue age-based “routine” screening with Pap's. Continue age-based “routine” screening with co-testing. Stop Pap's now. Stop Pap's now but start again if she has a new sexual partner.

2012 Consensus Guidelines: Women with prior hysterectomy No screening is necessary. Applies to women without a cervix and without a history of CIN2, CIN3, AIS, or cancer in the past 20 years. Evidence of adequate negative prior screening is not required ( USPSTF requires). Screening should not be resumed for any reason, including if a woman reports having a new sexual partner. Saslow et al. ACS/ASCCP/ASCP. CA Cancer J Clin 2012; 62: 147-72 and AJCP 2012; 137: 516 – 542. Moyer VA, et al. USPSTF. Ann Int Med 2012; 156: 880-91 ACOG Practice Bulletin #131, November 2012 NCCN Cervical Cancer Screening Guideline v. 2-2012. www.NCCN.org

Percentage of women who had a Pap test within 3 years by hysterectomy status and age group MMWR 2013;61(51):1043-1047

A 35 year old G1P1 presents after routine co-testing showing a negative Pap test and positive HPV testing. She was previously screened with cytology only but has not had screening in 5 years. She’s had multiple sexual partners in the past year but before was monogamous for 15 years What is the next step?? 1. Routine screening in 5 years. 2. Immediate colposcopy. 3. Repeat HPV testing in one year. 4. Repeat both cytology and HPV testing (cotesting) in one year.

2013 ASCCP consensus guidelines Women > age 30, Pap -, HPV + Wright TC, et al. J Lower Genital Tract Disease, 2007; 11: 201-222 and 223-239

She returns in one year. Cotesting results show Pap – HPV – What is the next step? Repeat cotesting in one year. Repeat cotesting in 3 years. Repeat cotesting in 5 years. Pap only in 3 years.

2013 ASCCP consensus guidelines Women > age 30, Pap -, HPV + Wright TC, et al. J Lower Genital Tract Disease, 2007; 11: 201-222 and 223-239

42 year old woman is Pap – HPV + Your lab uses genotyping and she is HPV 16 and 18 negative. What is the next step? Repeat cotesting in one year. Repeat cotesting in 3 years. Repeat cotesting in 5 years. Colposcopy.

Her cotesting in one year is Pap – HPV 16 +. What do you do now? Immediate colposcopy. Repeat cotesting in 1 year. Repeat cotesting in 3 years. Return to routine screening.

2013 ASCCP consensus guidelines Women > age 30, Pap -, HPV + Go back to Initial algorithm Wright TC, et al. J Lower Genital Tract Disease, 2007; 11: 201-222 and 223-239

Unsatisfactory Pap Unsat Pap's are unreliable for detecting cervical abnormalities. Conventional Pap: “obscuring factors” rendered Pap unsatisfactory. ThinPrep: can control for obscuring factors. Unsat Pap's arise largely from insufficient squamous cells. Caution: a negative HPV test cannot be relied on as it may be falsely negative because of an insufficient sample.

Life cycle of the SCJ Adolescents and young women Reproductive years Postmenopause

The cervical transformation process Apgar, Brotzman, Spitzer

Bring her in immediately for a repeat Pap. 31 year old presents for her “annual” Pap. Her last Pap was 4 years ago at a prenatal visit. No hx abnormal Pap's. She had sex last night and used a lot of lubrication. Because she has a hx of no-shows, you do her Pap today. It is unsatisfactory due to low numbers of squames. HPV is negative. What is the next step? Bring her in immediately for a repeat Pap. Pap and HPV in one year because she has no hx of abnormal Pap's. Ask the lab to repeat the HPV test. Repeat the Pap in 2-4 months.

2 unsats >> colpo

35 year old had a negative Pap 3 years ago. You decide to cotest her 35 year old had a negative Pap 3 years ago. You decide to cotest her. Her Pap is unsatisfactory but her HPV is + What is the next step? Repeat cotesting now. Repeat cotesting in one year. Repeat Pap in 2-4 months. Immediate colposcopy.

2 unsats >> colpo

Caution please! Colposcopy is recommended for women with 2 consecutive unsatisfactory Pap's

29 year old with negative Pap but no endocervical cells 29 year old with negative Pap but no endocervical cells. What is the next step? Routine screening. Ask the lab to do HPV testing. Repeat the Pap in 4-6 months.

A 35 year old had a Pap 3 years ago A 35 year old had a Pap 3 years ago. You decide to repeat the Pap instead of doing cotesting. Results show her Pap is negative but lacks endocervical cells. What is the next step? Request HPV testing now. Repeat her Pap in one year. Cotesting in one year. Routine screening (Pap in 3 years).

Cotesting preferred Discordant results

Are women with no endocervical cells at higher risk over time? No higher risk for CIN 3+ over time than women with a compete endocervical component. Would be expected however if true precancers had been missed. Lower rate of expected Pap abnormalities over time because most women with no endocervical cells are “older”. Older women have lower CIN 3+ risk.

65 year old postmenopausal woman Stratified squamous epithelium Apgar, Brotzman, Spitzer

Happy Pap-ing everyone!